EUVIMEDEUVIMED entdecken
Crossref

Discovery of New Pentapeptide Inhibitors Against Amyloid-β Aggregation Using Word2Vec and Molecular Simulation

Yin-Lei Han, Huan-Huan Yin, Chen Li iD, Jiangyue Du, Yi He iD, Yi-Xin Guan iD

ACS Chemical Neuroscience · 2025

DOI: 10.1021/acschemneuro.4c00661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Yin-Lei Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Peptide Fragments, Oligopeptides, Protein Aggregation, Pathological. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is characterized by the aggregation of amyloid-β (Aβ) peptides into toxic oligomers and fibrils. The efficacy of existing peptide inhibitors based on the central hydrophobic core (CHC) sequence of Aβ42 remains limited due to self-aggregation or poor inhibition. This study aimed to identify novel pentapeptide inhibitors with high similarity and low binding energy to the CHC region LVFFA using a new computational screening workflow based on Word2Vec and molecular simulation. The antimicrobial peptides and human brain protein sequences were used for training the Word2Vec model. After tuning the parameters of the Word2Vec model, 1017 pentapeptides with high similarity to LVFFA were identified. Molecular docking was employed to estimate the affinity of the pentapeptides for the target of Aβ14-42 pentamer, and 103 peptides with favorable docking scores were obtained. Finally, five pentapeptides with a low binding energy and high binding stability via molecular dynamics simulation were experimentally validated using thioflavin T assays. Surprisingly, one pentapeptide, i.e., PALIR, exhibited significant inhibition surpassing the positive control LPFFN. This study demonstrates an effective combinatorial strategy to discover new peptide inhibitors. With PALIR representing a promising lead candidate, further optimization of PALIR could aid in the development of improved therapies to prevent amyloid toxicity in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesPeptide FragmentsOligopeptidesProtein Aggregation, PathologicalHumansMolecular Docking SimulationMolecular Dynamics SimulationDrug DiscoveryAlzheimer DiseaseProtein Aggregates

Stichwörter der Autor:innen

Word2Vecaggregationamyloid-βmolecular dynamics simulationpentapeptide

Substanzen

Amyloid beta-PeptidesPeptide FragmentsOligopeptidesProtein Aggregates

Autor:innen und Institutionen

  • College of Chemical and Biological Engineering, Zhejiang University, Hangzhou 310058, China.
  • Department of General Practice, Sir Run Run Shaw Hospital of Zhejiang University, Hangzhou 310020, China.
  • Department of Chemical Engineering, University of Washington, Seattle, Washington 98195, United States.

ORCID-Profile: Chen Li, Yi He, Yi-Xin Guan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Han, Y. L., Yin, H. H., Li, C., Du, J., He, Y., & Guan, Y. X. (2025). Discovery of New Pentapeptide Inhibitors Against Amyloid-β Aggregation Using Word2Vec and Molecular Simulation. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00661

Vancouver

Han YL, Yin HH, Li C, Du J, He Y, Guan YX. Discovery of New Pentapeptide Inhibitors Against Amyloid-β Aggregation Using Word2Vec and Molecular Simulation. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00661

BibTeX
@article{Han2025,
  author = {Han, Yin-Lei and Yin, Huan-Huan and Li, Chen and Du, Jiangyue and He, Yi and Guan, Yi-Xin},
  title = {Discovery of New Pentapeptide Inhibitors Against Amyloid-β Aggregation Using Word2Vec and Molecular Simulation},
  journal = {ACS Chemical Neuroscience},
  year = {2025},
  doi = {10.1021/acschemneuro.4c00661}
}
Kostenlos starten →